Helix BioPharma Corp. (HBP) and Helix Immuno-Oncology (HIO) cooperate with leading academic centers, research centers and oncology clinics in Poland, Canada and USA. In Poland, the companies established cooperation with Maria Sklodowska-Curie Institute — Oncology Center, Military Institute of Medicine, the National Institute of Tuberculosis and Lung Diseases as well as the Mazovian Center for Treatment of Lung Diseases and Tuberculosis in Otwock. Furthermore, Helix Immuno-Oncology (HIO) cooperates with the Warsaw Medical University, Institute of Experimental Biology of the Polish Academy of Sciences, with the Institute of Hematology and Transfusion Medicine in Warsaw, Poznan University of Medical Science. The specialists cooperating with HIO among others include Prof. Cezary Szczylik, Prof. Sławomir Majewski, dr hab. Radosław Zagożdżon, dr hab. Magdalena Winiarska, Prof. Katarzyna Piwocka, Prof. Claudine Kieda. As part of international cooperation, Helix companies have established contacts, among others with University of Texas, University of Arizona , Moffitt Cancer Center, MD Anderson Cancer Center, Penn State Milton S. Hershey Medical Center, University Hospitals Case Medical Center, Cleveland, and National Research Council Canada.